[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:merkel-cell-carcinoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":200,"states":212},"Merkel Cell Carcinoma",31,27,[8,16,23,29,35,42,48,54,60,67,73,79,85,91,97,103,109,115,121,127,132,138,144,150,156,162,168,174,181,187,194],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT04975152","Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma",[12],"Phase 1","RECRUITING","2026-08-26T02:18:02.701182Z","2026-05-29T15:36:40.162110Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05583708","Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer",[20],"Phase 2","2026-08-26T02:15:03.757872Z","2026-05-05T02:43:29.698134Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT05496036","Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma",[20],"2026-08-26T02:17:59.904383Z","2026-05-05T02:43:29.139322Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT07288073","TIL Therapy in cSCC and MCC",[20],"2026-08-26T02:18:58.958025Z","2026-05-05T02:43:28.659766Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":40,"content_modified":41},"NCT06947928","Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma",[39],"Phase 2\u002FPhase 3","2026-08-26T02:16:39.977107Z","2026-05-05T02:43:27.250693Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT05100095","Hypofractionated Radiation Therapy for Merkel Cell Carcinoma",[20],"2026-08-26T02:19:00.742020Z","2026-05-05T02:43:27.246138Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT06940440","IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)",[12],"2026-08-26T02:16:35.654046Z","2026-05-05T02:35:31.870380Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT06223659","EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers",[20],"2026-08-26T02:16:02.918558Z","2026-05-05T02:43:27.591625Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":65,"content_modified":66},"NCT06814496","Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors",[64],"Phase 1\u002FPhase 2","2026-08-26T02:15:38.131683Z","2026-07-24T01:27:14.891188Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT06021626","A Study of CRD3874-SI in People With Solid Tumors",[12],"2026-08-26T02:16:32.589113Z","2026-07-05T05:32:16.744495Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT07080242","Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors",[12],"2026-08-26T02:15:59.318403Z","2026-07-05T05:32:16.735201Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT04902443","Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV",[12],"2026-08-26T02:17:27.435233Z","2026-06-18T12:24:02.872345Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT07197671","Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer",[12],"2026-08-26T02:15:58.452248Z","2026-05-05T02:43:29.735881Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT07115043","A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors",[64],"2026-08-26T02:15:56.561131Z","2026-05-05T02:43:29.700642Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT06444815","A Study of VET3-TGI in Patients With Solid Tumors",[12],"2026-08-26T02:17:46.653867Z","2026-05-05T02:43:29.507169Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT07027488","AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors",[12],"2026-08-26T02:17:57.117858Z","2026-05-05T02:43:29.505679Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT05267626","Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer",[64],"2026-08-26T02:19:18.331180Z","2026-05-05T02:43:28.878293Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT02479698","Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and\u002For JC Virus",[20],"2026-08-26T02:18:30.351130Z","2026-05-05T02:43:28.730025Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT05076760","MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors",[12],"2026-08-26T02:19:07.104270Z","2026-05-05T02:43:28.200826Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":71,"content_modified":131},"NCT05859074","A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer",[12],"2026-05-05T02:43:27.807952Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":136,"content_modified":137},"NCT05969860","At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer",[20],"2026-08-26T02:17:20.511551Z","2026-05-05T02:43:26.978986Z",{"nct_id":139,"title":140,"phases":141,"status":13,"updated_at":142,"content_modified":143},"NCT05086692","A Beta-only IL-2 ImmunoTherapY Study",[64],"2026-08-26T02:18:31.164304Z","2026-05-05T02:35:31.708594Z",{"nct_id":145,"title":146,"phases":147,"status":13,"updated_at":148,"content_modified":149},"NCT05896839","Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer",[64],"2026-08-26T02:19:11.399072Z","2026-05-05T02:35:31.620913Z",{"nct_id":151,"title":152,"phases":153,"status":13,"updated_at":154,"content_modified":155},"NCT05269381","Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors",[64],"2026-08-26T02:19:10.436356Z","2026-04-29T02:57:57.121665Z",{"nct_id":157,"title":158,"phases":159,"status":13,"updated_at":160,"content_modified":161},"NCT02471352","Studies of Dermatologic Diseases Biospecimen Acquisition Protocol",[],"2026-08-26T02:19:02.550788Z","2026-05-13T02:55:06.095687Z",{"nct_id":163,"title":164,"phases":165,"status":13,"updated_at":166,"content_modified":167},"NCT07215988","Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a \"Filter\" Observational Study",[],"2026-08-26T02:15:25.633039Z","2026-07-05T05:32:16.664484Z",{"nct_id":169,"title":170,"phases":171,"status":13,"updated_at":172,"content_modified":173},"NCT07285044","The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas",[20],"2026-08-26T02:16:24.135291Z","2026-07-05T05:32:16.672723Z",{"nct_id":175,"title":176,"phases":177,"status":178,"updated_at":179,"content_modified":180},"NCT07472322","ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1",[64],"NOT_YET_RECRUITING","2026-08-26T02:19:24.527214Z","2026-05-05T02:43:29.319219Z",{"nct_id":182,"title":183,"phases":184,"status":178,"updated_at":185,"content_modified":186},"NCT06039033","Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns",[],"2026-08-26T02:17:05.997056Z","2026-05-13T02:55:06.402478Z",{"nct_id":188,"title":189,"phases":190,"status":191,"updated_at":192,"content_modified":193},"NCT03935893","Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers",[20],"ACTIVE_NOT_RECRUITING","2026-08-03T03:19:35.241322Z","2026-05-05T02:43:26.987294Z",{"nct_id":195,"title":196,"phases":197,"status":191,"updated_at":198,"content_modified":199},"NCT06608511","Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers",[],"2026-08-03T02:07:36.529363Z","2026-05-13T02:55:06.554644Z",[201,205,209],{"biomarker":202,"count":203,"slug":204},"Programmed Cell Death 1 Ligand 1",4,"programmed-cell-death-1-ligand-1",{"biomarker":206,"count":207,"slug":208},"BRAF Gene",3,"braf-gene",{"biomarker":210,"count":207,"slug":211},"MRC1 wt Allele","mrc1-wt-allele",[213,217,221,225,228,232,235,238,241,244,247,250,253,256,259],{"state":214,"count":215,"slug":216},"Florida",11,"florida",{"state":218,"count":219,"slug":220},"Texas",8,"texas",{"state":222,"count":223,"slug":224},"California",6,"california",{"state":226,"count":223,"slug":227},"Pennsylvania","pennsylvania",{"state":229,"count":230,"slug":231},"New Jersey",5,"new-jersey",{"state":233,"count":230,"slug":234},"New York","new-york",{"state":236,"count":230,"slug":237},"Wisconsin","wisconsin",{"state":239,"count":207,"slug":240},"Georgia","georgia",{"state":242,"count":207,"slug":243},"Maryland","maryland",{"state":245,"count":207,"slug":246},"Michigan","michigan",{"state":248,"count":207,"slug":249},"Missouri","missouri",{"state":251,"count":207,"slug":252},"North Carolina","north-carolina",{"state":254,"count":207,"slug":255},"Ohio","ohio",{"state":257,"count":207,"slug":258},"Virginia","virginia",{"state":260,"count":207,"slug":261},"Washington","washington"]